abstract |
The present invention relates to macrocyclic compounds of formula (I): wherein W, n, R<1>, R<a>, R, R<3>, R<4>, M, Z, ring A and ring B are defined herein, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising them, and their use for the treatment or prevention of infection by hepatitis C virus. |